{"id":3141,"date":"2018-02-23T02:21:22","date_gmt":"2018-02-23T07:21:22","guid":{"rendered":"https:\/\/issels.com\/blog\/?p=3141"},"modified":"2018-02-11T17:38:17","modified_gmt":"2018-02-11T22:38:17","slug":"immunotherapy-makes-a-terminal-diagnosis-become-years-not-months","status":"publish","type":"post","link":"https:\/\/issels.com\/blog\/2018\/02\/23\/immunotherapy-makes-a-terminal-diagnosis-become-years-not-months\/","title":{"rendered":"Immunotherapy Makes a Terminal Diagnosis Become Years Not Months"},"content":{"rendered":"
\"Extending
Extending Your Life After Cancer May Now Be Attainable.<\/figcaption><\/figure>\n

At one time, a diagnosis of terminal cancer left little hope. Today, astounding developments in cancer treatment<\/a> have created a segment of “super survivors”<\/a> who live long past their terminal diagnosis.<\/p>\n

Living with “Terminal” Cancer?<\/strong><\/p>\n

Canadian teacher Anne-Marie Cerato is a prime example of the new super survivors. Eight years ago, at the age of 32, non-smoker Cerato underwent treatment for lung cancer<\/a>. Two years later, doctors found that the cancer had spread to Cerato’s other lung and she was diagnosed as terminal.<\/p>\n

Cerato decided to quit her job and spend her remaining months traveling the world. Amazingly, months stretched into years, and Cerato has not only married but is considering a return to teaching.<\/p>\n

The key to Cerato’s survival has been two pills a day of a drug called lorlatinib, which she takes as part of a clinical trial. Cerato’s tumors carry a rare gene reassignment, making her cancer the type that lorlatinib is designed to treat.<\/p>\n

New Cancer Treatment Provides Hope<\/strong><\/p>\n

According to Dr. Mark Doherty, an oncologist in Toronto, clinical trials of lung cancer immunotherapy treatments<\/a> have resulted in 20 percent of patients surviving the five-year point. Doherty pointed out that this response was “unheard of” with previous chemotherapy drugs.<\/p>\n

These patients are not considered cured. Rather, their diagnosis changes from a terminal illness to a chronic but treatable disease. Doctors follow up with regular scans to make sure the cancer has not progressed.<\/p>\n

State-of-the-Art Immunotherapy from Issels\u00ae<\/strong><\/p>\n

Our founder, Dr. Josef Issels<\/a>, was ahead of his time in developing non-toxic, personally tailored immunotherapy cancer treatments. Contact us<\/a> to learn how we are carrying on his legacy.<\/p>\n","protected":false},"excerpt":{"rendered":"

At one time, a diagnosis of terminal cancer left little hope. Today, astounding developments in cancer treatment have created a segment of “super survivors” who live long past their terminal diagnosis. Living with “Terminal” Cancer? Canadian teacher Anne-Marie Cerato is a prime example of the new super survivors. Eight years ago, at the age of … Continue reading Immunotherapy Makes a Terminal Diagnosis Become Years Not Months<\/span> →<\/span><\/a><\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[202,538,1],"tags":[666,219,483,665],"class_list":["post-3141","post","type-post","status-publish","format-standard","hentry","category-alternative-cancer-treatment","category-immunotherapy-for-cancer","category-uncategorized","tag-extending-life-diagnosis","tag-immunotherapy","tag-life-after-cancer","tag-terminal-diagnosis-breakthroughs"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/posts\/3141","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/comments?post=3141"}],"version-history":[{"count":2,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/posts\/3141\/revisions"}],"predecessor-version":[{"id":3150,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/posts\/3141\/revisions\/3150"}],"wp:attachment":[{"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/media?parent=3141"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/categories?post=3141"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/issels.com\/blog\/wp-json\/wp\/v2\/tags?post=3141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}